Our focus is to fund research, with the aim of finding a cure for neuroblastoma, an aggressive and often deadly childhood cancer that affects very young children. Almost half of children diagnosed with advanced disease will die, despite aggressive treatment. The group &
Headquarters:
Australia
Company Type:
SME
Company size:
Employees
Address:
null
LOW
spending power